Ledger.Open graph →
SEC Form D · filed March 25, 2024

NurExone Biologic Inc

Offering
$43K
Sold
$43K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BNEI-BRAK, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Lior Shaltiel · Bnei-Brak, L3Exec · DirectorYoram 4. Drucker · Bnei-Brak, L3ExecOded 4. Orgil · Bnei-Brak, L3DirectorJames 4. Richardson · Bnei-Brak, L3DirectorEran Ovadya · Bnei-Brak, L3ExecOded 4. Orgil · Bnei-Brak, L3DirectorJames 4. Richardson · Bnei-Brak, L3DirectorYoram 4. Drucker · Bnei-Brak, L3ExecEran Ovadya · Bnei-Brak, L3ExecLior Shaltiel · Bnei-Brak, L3Exec · DirectorAnton F. Klaveness · VANCOUVER, British Columbia, CanadaDirectorMichael K. Mckenna · VANCOUVER, British Columbia, CanadaExec · DirectorMichael F. Westlake · VANCOUVER, British Columbia, CanadaExecScott Taylor · VANCOUVER, British Columbia, CanadaDirectorChristopher K. Green · VANCOUVER, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗